CML-BC

AcronymDefinition
CML-BCChronic Myelogenous Leukemia in Blast Crisis
References in periodicals archive ?
In CML-BC patients, the most frequent grade 3-4 nonhematologic adverse events were pneumonia (11%), pyrexia (6%), diarrhea (4%), and asthenia (4%).
Investigator Assessment of Best Response to Nilotinib in Patients With CML-BC Myeloid Lymphoid Unknown Type (n = 87) (n = 27) (n = 6) Hematologic response 36% 37% 17% Stable disease 31% 26% 33% Progressive disease 18% 19% 33% Not evaluable 8% 4% 0% Missing 7% 15% 17% Note: Percentages may not add up to 100% because of rounding.